Literature DB >> 8902711

Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis.

O H Del Brutto1, N H Wadia, M Dumas, M Cruz, V C Tsang, P M Schantz.   

Abstract

Taenia solium cysticercosis is a major public health problem in several areas of the world. While the disease has a recognized etiologic agent, its definitive histological diagnosis is not possible in most cases because this parasite tends to lodge in cerebral tissues where routine biopsy is not feasible. Therefore, the diagnosis of human cysticercosis (and neurocysticercosis) should rest on the proper interpretation of the patients' symptoms together with data provided by radiological studies and immunologic tests for the detection of anticysticercal antibodies. Unfortunately, the pleomorphism of this parasitic disease creates confusion when non-specific clinical, radiological, or immunologic criteria alone are used to detect cases among populations or to diagnose hospitalized patients with neurological manifestations. We propose a chart of diagnostic criteria for human cysticercosis that objectively permit clinicians and health care workers to evaluate clinical, radiological, immunologic, and epidemiologic data of patients. The chart uses four degrees of criteria: absolute, major, minor, and epidemiologic, that were selected on the basis of their individual diagnostic strength. Interpretation of such criteria will result in three categories of diagnostic certainty: definitive, probable and possible, according to the likelihood that cysticercosis is present in a given person.

Entities:  

Mesh:

Year:  1996        PMID: 8902711     DOI: 10.1016/0022-510x(96)00130-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  52 in total

1.  Single CT (ring) lesion in epilepsy patients: a new observation.

Authors:  R K Garg; B Karak; A M Sharma; R Ojha; S Misra
Journal:  Indian J Pediatr       Date:  1999 Jan-Feb       Impact factor: 1.967

2.  NEUROCYSTICERCOSIS - A CLINICOPATHOLOGICAL APPRAISAL.

Authors:  S Kudesia; Vani Santosh; Ily Pal; Sarala DAS; S K Shankar
Journal:  Med J Armed Forces India       Date:  2017-06-26

3.  MRI and in vivo proton MR spectroscopy in a racemose cysticercal cyst of the brain.

Authors:  P N Jayakumar; H S Chandrashekar; S G Srikanth; A S Guruprasad; B Indira Devi; S K Shankar
Journal:  Neuroradiology       Date:  2003-11-12       Impact factor: 2.804

4.  Cysticercosis: Recent Advances in Diagnosis and Management of Neurocysticercosis.

Authors:  Linda S Yancey; Pedro J Diaz-Marchan; A Clinton White
Journal:  Curr Infect Dis Rep       Date:  2005-01       Impact factor: 3.725

Review 5.  Neurocysticercosis--New Millennium, ancient disease and unending debate.

Authors:  G Narula; K S Bawa
Journal:  Indian J Pediatr       Date:  2003-04       Impact factor: 1.967

6.  Taenia saginata metacestode antigenic fractions without affinity to concanavalin A are an important source of specific antigens for the diagnosis of human neurocysticercosis.

Authors:  Heliana B Oliveira; Gleyce A Machado; José R Mineo; Julia M Costa-Cruz
Journal:  Clin Vaccine Immunol       Date:  2010-02-03

7.  Differential diagnosis of cerebral tuberculomas.

Authors:  J Wadley
Journal:  J R Soc Med       Date:  1997-08       Impact factor: 5.344

Review 8.  Taenia solium Cysticercosis and Its Impact in Neurological Disease.

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

9.  Solitary cysticercosis of the biceps brachii in a vegetarian: a rare and unusual pseudotumor.

Authors:  Ibrahim Fikry Abdelwahab; Michael J Klein; George Hermann; Mohammed Abdul-Quader
Journal:  Skeletal Radiol       Date:  2003-05-03       Impact factor: 2.199

10.  Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments.

Authors:  Samuel Ong; David A Talan; Gregory J Moran; William Mower; Michael Newdow; Victor C W Tsang; Robert W Pinner
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.